Experimental Oncology

Aims & Scope

The Experimental Oncology is an English-language journal that publishes review articles, original contributions, short communications, case reports and technical advances presenting new data in the field of experimental and fundamental oncology.

Manuscripts should be written in English, contain original work, which has not been published or submitted for publication elsewhere.

View Aims & Scope

---

Metrics & Ranking

SJR (SCImago Journal Rank)

Year	Value
2024	0.241

Quartile

Year	Value
2024	Q4

h-index

Year	Value
2024	50

Journal Rank

Year	Value
2024	19000

Journal Citation Indicator

Year	Value
2024	145

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.

---

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• ROLE OF DENDRIMERS IN ADVANCED DRUG DELIVERY AND BIOMEDICAL APPLICATIONS: A REVIEW

  Citation: 56

  Authors: A, R, E, N, T, E, R, T, S, A, S

• NF-kB as a potential prognostic marker and a candidate for targeted therapy of cancer

  Citation: 49

  Authors: K.A., M.M., A.M., M.K., N.V.

• HIF-1 — A BIG CHAPTER IN THE CANCER TALE

  Citation: 41

  Authors: J

• Insights into the mechanism of natural terpenoids as NF-kB inhibitors: an overview on their anticancer potential

  Citation: 39

  Authors: H, N, T, R

• ROLE OF COMPONENTS OF microRNA MACHINERY IN CARCINOGENESIS

  Citation: 35

  Authors: R, S, S

• TRP GENES FAMILY EXPRESSION IN COLORECTAL CANCER

  Citation: 34

  Authors: Y, M E, I, A, S, K, O, I, B, Y Z, O, C

• L-ARGININE IS AN EFFECTIVE MEDICATION FOR PREVENTION OF ENDOTHELIAL DYSFUNCTION, A PREDICTOR OF ANTHRACYCLINE CARDIOTOXICITY IN PATIENTS WITH ACUTE LEUKEMIA

  Citation: 34

  Authors: I, G, T, I

• Role of nitric oxide in pathogenesis of tumor growth and its possible application in cancer treatment

  Citation: 30

  Authors: V.V., A.Y., I.K., B.B., D.Ya.

• The impact of maximal strength training on quality of life among women with breast cancer undergoing treatment

  Citation: 30

  Authors: R., J., A., M., E., R., A., S.

• Quinazoline compounds for antitumor treatment

  Citation: 27

  Authors: G.I.

---